Orgasm Inc. (2011)
| Theatrical Performance | ||
| Domestic Box Office | $49,001 | Details |
| Further financial details... | ||
Synopsis
Filmmaker Liz Canner takes a job editing erotic videos for a drug trial for a pharmaceutical company. Her employer is developing what they hope will be the first Viagra drug for women that wins FDA approval to treat a new disease: Female Sexual Dysfunction (FSD). Liz gains permission to film the company for her own documentary. Initially, she plans to create a movie about science and pleasure but she soon begins to suspect that her employer, along with a cadre of other medical companies, might be trying to take advantage of women (and potentially endanger their health) in pursuit of billion dollar profits. Orgasm Inc. is a look inside the medical industry and the marketing campaigns that are literally and figuratively reshaping our everyday lives around health, illness, desire—and that ultimate moment: orgasm.
Metrics
| Opening Weekend: | $8,773 (17.9% of total gross) |
| Legs: | 5.59 (domestic box office/biggest weekend) |
| Domestic Share: | 100.0% (domestic box office/worldwide) |
| Theater counts: | 1 opening theaters/3 max. theaters, 6.3 weeks average run per theater |
| Infl. Adj. Dom. BO | $73,901 |
Movie Details
| Domestic Releases: | February 11th, 2011 (Limited) by First Run Features, released as Orgasm Inc |
| MPA Rating: | Not Rated |
| Running Time: | 78 minutes |
| Cast, crew, or production detail: | Directing Yourself, Epilogue, Intertitle, Voiceover/Narration |
| Plot point: | Corporate Malfeasance, Medical and Hospitals, Pharmaceuticals, Study of Sexuality |
| Source: | Based on Real Life Events |
| Genre: | Documentary |
| Production Method: | Live Action |
| Creative Type: | Factual |
| Production/Financing Companies: | Chicken and Egg Pictures, Astrea Media |
| Production Countries: | United States |
| Languages: | English |
Weekend Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Feb 11, 2011 | 60 | $8,773 | 1 | $8,773 | $8,773 | 1 | |
| Feb 18, 2011 | 78 | $4,399 | -50% | 3 | $1,466 | $18,501 | 2 |
| Feb 25, 2011 | 105 | $198 | -95% | 1 | $198 | $21,365 | 3 |
| Mar 4, 2011 | 108 | $311 | +57% | 1 | $311 | $21,796 | 4 |
| Mar 11, 2011 | 93 | $2,686 | +764% | 3 | $895 | $24,864 | 5 |
| Mar 18, 2011 | 117 | $295 | -89% | 1 | $295 | $25,739 | 6 |
| Mar 25, 2011 | 89 | $5,454 | +1,749% | 2 | $2,727 | $31,840 | 7 |
| Apr 1, 2011 | 89 | $4,866 | -11% | 3 | $1,622 | $40,854 | 8 |
| Apr 15, 2011 | 105 | $500 | 1 | $500 | $44,916 | 10 | |
| Apr 22, 2011 | 119 | $155 | -69% | 1 | $155 | $45,473 | 11 |
| May 13, 2011 | 122 | $481 | 1 | $481 | $46,104 | 14 | |
| Jun 3, 2011 | 112 | $101 | 1 | $101 | $47,622 | 17 |
Daily Box Office Performance
| Date | Rank | Gross | %YD | %LW | Theaters | Per Theater | Total Gross | Days |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2011 | 71 | $757 | 3 | $252 | $19,258 | 11 |
Weekly Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Feb 11, 2011 | 67 | $8,773 | 1 | $8,773 | $14,102 | 1 | |
| Feb 18, 2011 | 72 | $7,065 | -19% | 3 | $2,355 | $21,167 | 2 |
| Feb 25, 2011 | 107 | $318 | -95% | 1 | $318 | $21,485 | 3 |
| Mar 4, 2011 | 106 | $693 | +118% | 1 | $693 | $22,178 | 4 |
| Mar 11, 2011 | 100 | $2,756 | +298% | 3 | $919 | $24,934 | 5 |
| Mar 18, 2011 | 115 | $942 | -66% | 1 | $942 | $26,386 | 6 |
| Mar 25, 2011 | 89 | $9,602 | +919% | 2 | $4,801 | $35,988 | 7 |
| Apr 1, 2011 | 90 | $8,428 | -12% | 3 | $2,809 | $44,416 | 8 |
| Apr 15, 2011 | 112 | $902 | 1 | $902 | $45,318 | 10 | |
| Apr 22, 2011 | 124 | $305 | -66% | 1 | $305 | $45,623 | 11 |
| May 13, 2011 | 120 | $1,203 | 1 | $1,203 | $46,826 | 14 | |
| May 27, 2011 | 112 | $236 | 1 | $236 | $47,521 | 16 | |
| Jun 3, 2011 | 117 | $282 | +19% | 1 | $282 | $47,803 | 17 |
| Jun 17, 2011 | 111 | $155 | 1 | $155 | $49,001 | 19 |
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.
Synopsis
Filmmaker Liz Canner takes a job editing erotic videos for a drug trial for a pharmaceutical company. Her employer is developing what they hope will be the first Viagra drug for women that wins FDA approval to treat a new disease: Female Sexual Dysfunction (FSD). Liz gains permission to film the company for her own documentary. Initially, she plans to create a movie about science and pleasure but she soon begins to suspect that her employer, along with a cadre of other medical companies, might be trying to take advantage of women (and potentially endanger their health) in pursuit of billion dollar profits. Orgasm Inc. is a look inside the medical industry and the marketing campaigns that are literally and figuratively reshaping our everyday lives around health, illness, desire—and that ultimate moment: orgasm.
Metrics
| Opening Weekend: | $8,773 (17.9% of total gross) |
| Legs: | 5.59 (domestic box office/biggest weekend) |
| Domestic Share: | 100.0% (domestic box office/worldwide) |
| Theater counts: | 1 opening theaters/3 max. theaters, 6.3 weeks average run per theater |
| Infl. Adj. Dom. BO | $73,901 |
Movie Details
| Domestic Releases: | February 11th, 2011 (Limited) by First Run Features, released as Orgasm Inc |
| MPA Rating: | Not Rated |
| Running Time: | 78 minutes |
| Cast, crew, or production detail: | Directing Yourself, Epilogue, Intertitle, Voiceover/Narration |
| Plot point: | Corporate Malfeasance, Medical and Hospitals, Pharmaceuticals, Study of Sexuality |
| Source: | Based on Real Life Events |
| Genre: | Documentary |
| Production Method: | Live Action |
| Creative Type: | Factual |
| Production/Financing Companies: | Chicken and Egg Pictures, Astrea Media |
| Production Countries: | United States |
| Languages: | English |
Weekend Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Feb 11, 2011 | 60 | $8,773 | 1 | $8,773 | $8,773 | 1 | |
| Feb 18, 2011 | 78 | $4,399 | -50% | 3 | $1,466 | $18,501 | 2 |
| Feb 25, 2011 | 105 | $198 | -95% | 1 | $198 | $21,365 | 3 |
| Mar 4, 2011 | 108 | $311 | +57% | 1 | $311 | $21,796 | 4 |
| Mar 11, 2011 | 93 | $2,686 | +764% | 3 | $895 | $24,864 | 5 |
| Mar 18, 2011 | 117 | $295 | -89% | 1 | $295 | $25,739 | 6 |
| Mar 25, 2011 | 89 | $5,454 | +1,749% | 2 | $2,727 | $31,840 | 7 |
| Apr 1, 2011 | 89 | $4,866 | -11% | 3 | $1,622 | $40,854 | 8 |
| Apr 15, 2011 | 105 | $500 | 1 | $500 | $44,916 | 10 | |
| Apr 22, 2011 | 119 | $155 | -69% | 1 | $155 | $45,473 | 11 |
| May 13, 2011 | 122 | $481 | 1 | $481 | $46,104 | 14 | |
| Jun 3, 2011 | 112 | $101 | 1 | $101 | $47,622 | 17 |
Daily Box Office Performance
| Date | Rank | Gross | %YD | %LW | Theaters | Per Theater | Total Gross | Days |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2011 | 71 | $757 | 3 | $252 | $19,258 | 11 |
Weekly Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Feb 11, 2011 | 67 | $8,773 | 1 | $8,773 | $14,102 | 1 | |
| Feb 18, 2011 | 72 | $7,065 | -19% | 3 | $2,355 | $21,167 | 2 |
| Feb 25, 2011 | 107 | $318 | -95% | 1 | $318 | $21,485 | 3 |
| Mar 4, 2011 | 106 | $693 | +118% | 1 | $693 | $22,178 | 4 |
| Mar 11, 2011 | 100 | $2,756 | +298% | 3 | $919 | $24,934 | 5 |
| Mar 18, 2011 | 115 | $942 | -66% | 1 | $942 | $26,386 | 6 |
| Mar 25, 2011 | 89 | $9,602 | +919% | 2 | $4,801 | $35,988 | 7 |
| Apr 1, 2011 | 90 | $8,428 | -12% | 3 | $2,809 | $44,416 | 8 |
| Apr 15, 2011 | 112 | $902 | 1 | $902 | $45,318 | 10 | |
| Apr 22, 2011 | 124 | $305 | -66% | 1 | $305 | $45,623 | 11 |
| May 13, 2011 | 120 | $1,203 | 1 | $1,203 | $46,826 | 14 | |
| May 27, 2011 | 112 | $236 | 1 | $236 | $47,521 | 16 | |
| Jun 3, 2011 | 117 | $282 | +19% | 1 | $282 | $47,803 | 17 |
| Jun 17, 2011 | 111 | $155 | 1 | $155 | $49,001 | 19 |
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.